Wolverine Trading, LLC Co Diagnostics, Inc. Call Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$1.39 - $3.24 $7,088 - $16,524	-5,100 Reduced 31.29%	11,200 $17,000
Q4 2022 Feb 14, 2023	BUY	$2.32 - $3.68 $37,816 - $59,984	16,300 New	16,300 $41,000
Q2 2022 Aug 15, 2022	SELL	$3.76 - $6.29 $77,832 - $130,203	-20,700 Reduced 64.49%	11,400 $61,000
Q1 2022 May 16, 2022	SELL	$5.03 - $9.61 $124,744 - $238,328	-24,800 Reduced 43.59%	32,100 $204,000
Q4 2021 Feb 14, 2022	BUY	$8.12 - $10.37 $229,795 - $293,471	28,300 Added 98.95%	56,900 $517,000
Q3 2021 Nov 12, 2021	SELL	$7.48 - $11.38 $6,732 - $10,242	-900 Reduced 3.05%	28,600 $279,000
Q2 2021 Aug 06, 2021	SELL	$7.16 - $9.56 $42,244 - $56,404	-5,900 Reduced 16.67%	29,500 $263,000
Q1 2021 May 14, 2021	SELL	$8.52 - $19.21 $300,756 - $678,113	-35,300 Reduced 49.93%	35,400 $302,000
Q4 2020 Feb 12, 2021	BUY	$9.3 - $15.19 $169,260 - $276,458	18,200 Added 34.67%	70,700 $688,000
Q3 2020 Nov 13, 2020	BUY	$8.24 - $30.8 $61,800 - $231,000	7,500 Added 16.67%	52,500 $731,000
Q2 2020 Aug 13, 2020	BUY	$7.46 - $23.42 $335,700 - $1.05 Million	45,000 New	45,000 $785,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.